MAGNOLIA CAPITAL MANAGEMENT LTD Buys 2, Sells 3 in 4th Quarter

MAGNOLIA CAPITAL MANAGEMENT LTD recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

PO BOX 330 COLD SPRING, NY 10516

As of the latest 13F report, the guru’s equity portfolio contained 132 stocks valued at a total of $98.00Mil. The top holdings were SPY(15.30%), QQQ(10.86%), and IJH(6.66%).

According to GuruFocus data, these were MAGNOLIA CAPITAL MANAGEMENT LTD’s top five trades of the quarter.

Vanguard Value ETF


During the quarter, MAGNOLIA CAPITAL MANAGEMENT LTD bought 4,690 shares of ARCA:VTV for a total holding of 6,970. The trade had a 0.67% impact on the equity portfolio. During the quarter, the stock traded for an average price of $136.83.

On 01/18/2023, Vanguard Value ETF traded for a price of $141.01 per share and a market cap of $100.01Bil. The stock has returned -2.09% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, Vanguard Value ETF has a price-earnings ratio of 15.89 and a price-book ratio of 2.71.

Caterpillar Inc


The guru sold out of their 1,000-share investment in NYSE:CAT. Previously, the stock had a 0.18% weight in the equity portfolio. Shares traded for an average price of $217.7 during the quarter.

On 01/18/2023, Caterpillar Inc traded for a price of $252.82 per share and a market cap of $131.57Bil. The stock has returned 11.73% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Caterpillar Inc has a price-earnings ratio of 18.36, a price-book ratio of 8.44, a price-earnings-to-growth (PEG) ratio of 1.00, a EV-to-Ebitda ratio of 13.74 and a price-sales ratio of 2.40.

The price-to-GF Value ratio is 1.05, earning the stock a GF Value rank of 5.

Vanguard Health Care ETF


The guru established a new position worth 660 shares in ARCA:VHT, giving the stock a 0.17% weight in the equity portfolio. Shares traded for an average price of $241.69 during the quarter.

On 01/18/2023, Vanguard Health Care ETF traded for a price of $244.54 per share and a market cap of $17.02Bil. The stock has returned 0.59% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, Vanguard Health Care ETF has a price-earnings ratio of 22.97 and a price-book ratio of 4.57.

Health Care Select Sector SPDR


MAGNOLIA CAPITAL MANAGEMENT LTD reduced their investment in ARCA:XLV by 1,220 shares. The trade had a 0.16% impact on the equity portfolio. During the quarter, the stock traded for an average price of $132.05.

On 01/18/2023, Health Care Select Sector SPDR traded for a price of $132.92 per share and a market cap of $40.85Bil. The stock has returned 2.11% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, Health Care Select Sector SPDR has a price-earnings ratio of 22.41 and a price-book ratio of 4.73.

Bristol-Myers Squibb Co


The guru sold out of their 2,000-share investment in NYSE:BMY. Previously, the stock had a 0.16% weight in the equity portfolio. Shares traded for an average price of $75.40000000000001 during the quarter.

On 01/18/2023, Bristol-Myers Squibb Co traded for a price of $72.14 per share and a market cap of $153.38Bil. The stock has returned 14.50% over the past year.

GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Bristol-Myers Squibb Co has a price-earnings ratio of 23.50, a price-book ratio of 4.69, a price-earnings-to-growth (PEG) ratio of 2.94, a EV-to-Ebitda ratio of 9.57 and a price-sales ratio of 3.35.

The price-to-GF Value ratio is 0.96, earning the stock a GF Value rank of 6.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.